Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-03-21
2006-03-21
Whisenant, Ethan (Department: 1634)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007200
Reexamination Certificate
active
07015203
ABSTRACT:
The invention relates to novel erythromycin analogs and azalides, particularly ones with novel C-13 substituents, and to pharmaceutically acceptable salts thereof. The compounds of this invention are antibacterial agents that may be used to treat various bacterial and protozoa infections. The invention also relates to pharmaceutical compositions containing such compounds and to methods of treating bacterial protozoa infections by administering such compounds. The invention also relates to methods of preparing such compounds and to intermediates useful in such preparation.
REFERENCES:
patent: 3652537 (1972-03-01), Massey et al.
patent: 3923784 (1975-12-01), Kierstead et al.
patent: 4328334 (1982-05-01), Kobrehel et al.
patent: 4474768 (1984-10-01), Bright
patent: 4585759 (1986-04-01), Nagel
patent: 4886792 (1989-12-01), Djokic et al.
patent: 5141926 (1992-08-01), Weber et al.
patent: 5332807 (1994-07-01), Waddell et al.
patent: 5441939 (1995-08-01), Yang
patent: 5523399 (1996-06-01), Asaka et al.
patent: 5824513 (1998-10-01), Katz et al.
patent: 5985844 (1999-11-01), Heck et al.
patent: 6043226 (2000-03-01), Lundy et al.
patent: 6043227 (2000-03-01), Cheng et al.
patent: 6100240 (2000-08-01), Cheng et al.
patent: 6159945 (2000-12-01), Wu
patent: 6162794 (2000-12-01), Wu
patent: 6248719 (2001-06-01), Wu
patent: 6271255 (2001-08-01), Leadlay et al.
patent: 6291656 (2001-09-01), Wu
patent: 6329345 (2001-12-01), Rafka et al.
patent: 6339063 (2002-01-01), Kropp et al.
patent: 6407074 (2002-06-01), Bronk et al.
patent: 6420536 (2002-07-01), Bronk et al.
patent: 6518251 (2003-02-01), Cheng et al.
patent: 2002/0025937 (2002-02-01), Wu
patent: 2003/0013665 (2003-01-01), Kaneko
patent: 2003/0100518 (2003-05-01), Wu et al.
patent: 0105155 (1999-04-01), None
patent: 0508726 (1992-10-01), None
patent: 2691464 (1993-11-01), None
patent: 19186 (1972-12-01), None
patent: WO 9313663 (1993-07-01), None
patent: WO 9900124 (1999-01-01), None
patent: WO 9935156 (1999-07-01), None
patent: WO 9935157 (1999-07-01), None
patent: WO 03014136 (2003-02-01), None
Djokic S., et al.,J. Chem. Res., SYNOP, 1988, (5), pp. 152-153, Part 13, “Erythromycin series Synthesis and structure elucidation of 10-dihydro- 10-deoxo- 11-methyl-11- azaerythromycin A”.
Djokic S., et al.,J. Chem. Soc. Perkins Transl1 (1986), pp, pp. 1881-1890.
Jacobsen, John R., et al.,Precursor-Directed Biosynthesis of Erythromycin Analogs by an Engineered Polyketide Synthase, Science, vol. 277, pp. 367-369, (Jul. 18, 1997).
Blize Alan Elwood
Dirlam John Philip
McArthur Hamish Alastair Irvine
Benson Gregg C.
Forman Frank W.
Pfizer Inc.
Whisenant Ethan
LandOfFree
Macrolides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrolides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrolides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3613281